PatientsMap
PatientsMap is a large-scale database that contains data collected from physicians in four of the world’s major countries. Providing disease-related market data, it is helpful as a very versatile tool that can be used to address a wide range of issues from the development of new treatments to their post-market launch.
When you are faced with problems such as …?
- Difficulty selecting diseases for which new treatments should be developed,
- Difficulty estimating the number of physicians needed to achieve sales,
- Uncertainty about visit overlap for a particular disease for which new products are indicated is hindering indication expansion, and
- Being unable to understand competitors’ current promotions, etc.
Services overview
PatientsMap is a product that allows you to obtain comprehensive information on the treatment landscape and market size of more than approximately 1,000 diseases including rare diseases, unmet needs, and the promotional status of various pharmaceutical manufacturers.
The data on physicians' unmet needs for "diseases that require new treatments" gives PatientsMap its own unique value.
Treatment landscape and market size
PatientsMap provides data on treatment landscape by disease, number of patients, and number of treating physicians by disease.
Physicians’ unmet needs
PatientsMap highlights diseases that require new treatments and why.
Promotions
PatientsMap provides data on the number of MR visits, online meetings, e-detailing, and their reliability.
*Survey items may vary depending on the product.
Product features
PatientsMap is an optimal product to understand the overall trend in a disease area with a large sample size and wide coverage.
It can also be used to compare and analyze the data chronologically or by country based on data collected in the same survey frame.
One of the largest physician surveys in Japan
It is one of the largest physician surveys in Japan.
(As of October 2024, it covers approximately 86% of designated intractable diseases.)
It can help you in various areas such as research and development, business and product strategy, market research, and sales and marketing.
Insight into treatment landscape
PatientsMap can help you design control strategies for each segment as it can show a detailed treatment landscape by physician specialty or facility size.Insight into disease market size
PatientsMap can help you by providing fundamental data that allow you to understand market size and make investment decisions based on information about the number of patients and physicians in each disease area.Insight into disease market concentration
PatientsMap can help you understand market concentration based on the number of patients and physicians to effectively narrow down target markets.Insight into unmet needs
PatientsMap can help you understand the differences in the need for new therapy for each disease, from common diseases to rare diseases, and the reasons for these differences, so the direction and priority of new treatment development can be considered.Insight into the accuracy of physician targeting
The Japanese version of PatientsMap data can help you assess target physician coverage through target matching with DCF codes and evaluate targeting accuracy.Insight into competitor promotions
PatientsMap can help you to understand the reach and reliability of each pharmaceutical manufacturer’s promotional activities by information media so you can understand the competitive landscape for treating physicians.Market size and treatment status analysis
Analysis of unmet needs
Analysis of the promotional status of each pharmaceutical company
please contact us.
- When considering a disease for which new treatments should be developed,
- When verifying the disease market for in-licensed new developments or considering a partnered licensee,
- When estimating the number of physicians needed to achieve sales,
- When attempting to capture visit overlap for a particular disease to expand the product indications for that disease, and
- When evaluating the current target physicians, etc.